SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself

…, M Raftery, T Kallinich, MA Mall, S Angermair… - Nature …, 2021 - nature.com
The pathogenesis of severe COVID-19 reflects an inefficient immune reaction to SARS-CoV-2.
Here we analyze, at the single cell level, plasmablasts egressed into the blood to study …

SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition

A Sattler, S Angermair, H Stockmann… - The Journal of …, 2020 - Am Soc Clin Investig
Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS–CoV-2). So far, viral targets of cellular …

[HTML][HTML] High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

…, A Rocco, M Steinbrenner, S Angermair… - Brain, behavior, and …, 2021 - Elsevier
Background COVID-19 intensive care patients can present with neurological syndromes,
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some …

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

…, TC Jones, F Heinrich, S Frischbutter, S Angermair… - Nature, 2021 - nature.com
SARS-CoV-2 is a single-stranded RNA virus that causes COVID-19. Given its acute and often
self-limiting course, it is likely that components of the innate immune system play a central …

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

…, F Schwab, P Gastmeier, S Treskatsch, S Angermair… - Critical Care, 2022 - Springer
Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment
options for critically ill COVID-19 patients. However, there are a growing number of cases that …

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

…, FP Mockenhaupt, F Tacke, S Treskatsch, S Angermair… - Infection, 2020 - Springer
Purpose Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide
causing a global health emergency. Pa-COVID-19 aims to provide comprehensive data …

In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study

S Angermair, JH Hardenberg, K Rubarth, F Balzer… - Scientific Reports, 2024 - nature.com
The COVID-19 pandemic has posed a major challenge to healthcare systems globally.
Millions of people have been infected, and millions of deaths have been reported worldwide. …

[HTML][HTML] Critical illness and systemic inflammation are key risk factors of severe acute kidney injury in patients with COVID-19

…, H Mueller-Redetzky, S Angermair… - Kidney International …, 2021 - Elsevier
Introduction Acute kidney injury (AKI) is an important complication in COVID-19, but its precise
etiology has not fully been elucidated. Insights into AKI mechanisms may be provided by …

[PDF][PDF] Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry

…, L Budzinski, P Durek, M Witkowski, S Angermair… - Cell Host & Microbe, 2023 - cell.com
The commensal microflora provides a repertoire of antigens that illicit mucosal antibodies. In
some cases, these antibodies can cross-react with host proteins, inducing autoimmunity, or …

Cardiac arrhythmias in patients with COVID-19: lessons from 2300 telemetric monitoring days on the intensive care unit

…, P Kamieniarz, D Zieckler, J Kruse, S Angermair… - Journal of …, 2021 - Elsevier
Background Patients with COVID-19 seem to be prone to the development of arrhythmias.
The objective of this trial was to determine the characteristics, clinical significance and …